Pregnancy

Gold compound
#Alzheimer's #BioInnovation Institute #Biotech hubs #Cognition Therapeutics #India #Interview #Market reporting #Neurodegenerative disorders #Neuroscience #Pregnancy #Start-ups #Women's health

Podcast: Where are scientists making waves in drug discovery?

This is the latest episode of the free DDW narrated podcast, titled “Where are scientists making waves in drug discovery?”, which covers three articles written for DDW Volume 24 – Issue 3, Summer 2023. They are called: “How pharma is targeting advances in Alzheimer’s treatments”, “The start-up disrupting… Read More

#News

gut epithelium
#Antidepressants #Anxiety disorder #Depression #Gut-brain interaction #Pregnancy

Could the gut epithelium be a new target for antidepressants?

Researchers have discovered new connections between the gut and brain that hold promise for more targeted treatments for depression and anxiety.  The findings could also help prevent digestive issues in children by limiting the transmission of antidepressants during pregnancy.   The study,… Read More

#News #Trending News

Pregnancy sickness
#Pregnancy #University of Cambridge #University of Southern California #Women's health

Scientists discover potential treatment for pregnancy sickness

A new study has shown why seven in 10 women experience nausea and vomiting during pregnancy – and why some women become so sick they need to be admitted to hospital. It is caused by GDF15, a hormone produced by the foetus. The new study suggests… Read More

#News

#FDA #Immunology / Virology & Vaccines #Pfizer #Pregnancy #Respiratory syncytial virus

FDA approves RSV vaccine to protect babies from birth

The US Food and Drug Administration (FDA) has approved the first vaccine for pregnant individuals to prevent respiratory syncytial virus (RSV) in infants. Pfizer’s Abrysvo (Respiratory Syncytial Virus Vaccine) was approved for use at 32-36 weeks gestational age of pregnancy to prevent lower respiratory tract disease (LRTD) and severe LRTD… Read More

#News #Regulatory

#BioInnovation Institute #Pregnancy #Start-ups #Women's health

The start-up disrupting the field of women’s reproductive health

Listen to this article on the DDW Podcast: DDW’s Diana Spencer speaks to Alok Javali, CSO of dawn-bio, a new addition to BioInnovation Institute’s (BII) Venture Lab acceleration programme, about the lack of innovation in women’s reproductive health and the company’s plans to fill the vacuum. Earlier this year, dawn-bio was… Read More

#Exclusive Content #Start-up Zone

Pregnant woman in hospital
#Janssen #Phase II trial #Pregnancy #Trial data

Janssen reveals positive trial data for nipocalimab

Janssen has announced positive results from the proof-of-concept Phase II UNITY trial for the treatment of pregnant individuals at high risk of early-onset severe (EOS) haemolytic disease of the foetus and newborn (HDFN). A statistically significant (54%) proportion of participants who received nipocalimab achieved the primary… Read More

#News

Vaccination in pregnancy
#FDA #Pregnancy #Tdap #Whooping cough

First-ever Tdap vaccine approved by the FDA

Boostrix has become the first approved vaccine in the US to help protect infants younger than two months from pertussis (whooping cough).  The US Food and Drug Administration (FDA) has approved Boostrix (tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed [Tdap]) for immunisation… Read More

#News